EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-ND 4.0

Meropenem‐Induced Possible Mixed Drug‐Induced Liver Injury With Cholestatic Evolution: A Case Report Evaluated Using the Updated RUCAM (2016)

Nidal Mutawodeh, Sarah Saife iD, Akram Shalaby, Kamaleldein Einar, Motasem Kamal, Malik Hijaz, Tariq Hamadneh

Clinical Case Reports · 2026-06 · 14 (6)

DOI: 10.1002/ccr3.72792 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Case Reports, online erschienen am 22.05.2026. Verfasst von Nidal Mutawodeh und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Faculty of Medicine and Health Sciences An-Najah National University Nablus Palestine. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug‐induced liver injury (DILI) remains a diagnosis of exclusion and requires systematic causality assessment. Meropenem is generally considered hepatically safe; however, rare cases of idiosyncratic DILI have been reported. We describe a 33‐year‐old female who developed progressive elevation of liver tests following exposure to meropenem. Based on R ‐value calculation, the liver injury pattern was mixed at presentation and peak, with transient hepatocellular features followed by evolution toward a cholestatic pattern during recovery. Extensive imaging, endoscopic evaluation, and serologic testing excluded biliary obstruction, viral hepatitis, and autoimmune disease. Causality assessment using the updated Roussel Uclaf Causality Assessment Method (RUCAM, 2016) yielded a score of 4, indicating possible DILI. This case expands the demographic spectrum of reported meropenem‐associated DILI and underscores the importance of early R ‐value calculation, formal RUCAM‐based causality assessment, and prompt withdrawal of the suspected agent.

Schlagwörter

Stichwörter der Autor:innen

RUCAM (2016)case reportdrug‐induced liver injurymeropenemmixed liver injuryupdated RUCAM

Autor:innen und Institutionen

  • Department of Medicine, Faculty of Medicine and Health Sciences An-Najah National University Nablus Palestine.
  • University Hospitals Cleveland Ohio USA.
  • Department of Lymphoma/Myeloma Anderson Cancer Center Houston Texas USA.
  • Grand Strand Medical Center Myrtle Beach South Carolina USA.

ORCID-Profile: Sarah Saife

Zitieren

APA

Mutawodeh, N., Saife, S., Shalaby, A., Einar, K., Kamal, M., Hijaz, M., & Hamadneh, T. (2026). Meropenem‐Induced Possible Mixed Drug‐Induced Liver Injury With Cholestatic Evolution: A Case Report Evaluated Using the Updated RUCAM (2016). Clinical Case Reports, 14(6). https://doi.org/10.1002/ccr3.72792

Vancouver

Mutawodeh N, Saife S, Shalaby A, Einar K, Kamal M, Hijaz M, et al. Meropenem‐Induced Possible Mixed Drug‐Induced Liver Injury With Cholestatic Evolution: A Case Report Evaluated Using the Updated RUCAM (2016). Clinical Case Reports. 2026;14(6). doi:10.1002/ccr3.72792

BibTeX
@article{Mutawodeh2026,
  author = {Mutawodeh, Nidal and Saife, Sarah and Shalaby, Akram and Einar, Kamaleldein and Kamal, Motasem and Hijaz, Malik and Hamadneh, Tariq},
  title = {Meropenem‐Induced Possible Mixed Drug‐Induced Liver Injury With Cholestatic Evolution: A Case Report Evaluated Using the Updated RUCAM (2016)},
  journal = {Clinical Case Reports},
  year = {2026},
  volume = {14},
  number = {6},
  doi = {10.1002/ccr3.72792}
}
Kostenlos starten →